JPRN-UMIN000005901已完成3 期
A phase III randomized trial of adjuvant therapy with irsogladine maleate for the patient with completely resected non-small cell lung cancer - A phase III trial of adjuvant therapy with irsogladine maleate for the resected lung cancer patient
Japanese Northern East Area Thoracic Surgery Study Group (JNETS)0 个研究点目标入组 310 人开始时间: 2011年7月2日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 310
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 25years-old 至 74years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •multiple cancer within 5 years sever organ failure past history of radiotherapy/chemotherapy women with pregnancy or breast feeding
研究者
相似试验
已完成
3 期
A randomized phase III trial of adjuvant therapy with locoregional IFN-beta versus observation in stage II/III cutaneous melanoma (JCOG1309, J-FERON Trial)Cutaneous melanomaJPRN-UMIN000017494Japan Clinical Oncology Group (JCOG)240
招募中
不适用
Randomized Phase III Trial of the need for adjuvant chemotherapy in stage I epithelial ovarian cancer after comprehensive staging surgeryKCT0005869The Catholic University of Korea, Seoul St. Mary's Hospital360
招募中
3 期
Randomized Phase III Trial of the need for adjuvant chemotherapy in stage I epithelial ovarian cancer after comprehensive staging surgeryStage I epithelial ovarian cancer after comprehensive staging surgeryJPRN-UMIN000008481Japanese Gynecologic Oncology Group360
招募中
3 期
Japanese Gynecologic Oncology Group 3020 (ECO trial)Early OvarianCancerD000077216Epithelial ovarian cancerJPRN-jRCTs031180423TANABE HIROSHI300
已完成
不适用
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryPER-155-08EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG),